Removing a Potential MRI Risk - Literally
More than 40 million MRI scans are carried out every year in the U.S. In about one out of three, patients get an infusion containing the metal gadolinium as a contrast agent to improve imaging.
Because contrast MRIs sometimes lead to potentially life-threatening complications, the FDA issued a warning against contrast MRIs for patients with kidney disease. Rebecca Abergel studies the chemical biology of metals, with a research focuses on organic molecules that can sequester and eliminate metals in the body, a chemical process known as chelation. She is using her Bakar Fellow support to evaluate the effectiveness of a chelating drug she has developed.